IP Library Granted Patent US 12,402,835
Granted Patent B2
US 12,402,835 · App. 18/390,711 · Granted Sep 2, 2025

Catheter and actuator systems and methods

Inventors: Nasser Rafiee (Andover, MA); Biwei MacDonald (Andover, MA); Morgan House (Andover, MA); Koosha Rafiee (Andover, MA); Mai Le Diep (Andover, MA)
Assignee: Transmural Systems LLC
A61B5/6859A61B5/283A61B18/1492A61B2017/0003A61B2018/00279A61B2018/00369A61B2018/00601A61B2018/00839A61M25/0074
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,402,835
App. No.
18/390,711
Granted
Sep 2, 2025
Kind
B2
Abstract

The disclosure provides various embodiments of systems to facilitate the cutting of tissue structures and other tissue structures percutaneously.

Claims (28)

1. A method of performing a medical procedure, comprising:

providing a medical device, the medical device including:

an elongate tether having a proximal end configured to be anchored to a proximal anchor point outside of a patient's anatomy and a distal end having a tissue anchor disposed thereon to penetrate through myocardial tissue to permit tension to be applied to and maintained along the elongate tether when the proximal end of the elongate tether is anchored to the proximal anchor point and the tissue anchor is anchored into myocardial tissue;

a first tubular catheter surrounding the elongate tether and being slidably displaceable along and with respect to the elongate tether when the elongate tether is under tension, the first tubular catheter having a proximal end, a distal end, and a cutter; and

a second tubular catheter surrounding the first tubular catheter and being slidably displaceable along and with respect to the first tubular catheter, the second tubular catheter having a proximal end and a distal end;

directing the medical device to a target location inside a patient's left ventricle proximate a native tissue obstruction in a left ventricular outflow tract of the patient;

placing the distal end of the second tubular catheter in a first location located proximally with respect to the tissue obstruction;

placing the distal end of the first tubular catheter in a second location located distally with respect to the tissue obstruction;

penetrating the myocardial tissue with the tissue anchor to secure the distal end of the elongate tether in place with respect to the myocardium;

orienting the cutter of the first tubular catheter toward the native tissue obstruction; and

reciprocating the first tubular catheter along the elongate tether to cause the cutter to cut into the native tissue.

2. The method of claim 1 , wherein the first tubular catheter includes a distally-facing flush port configured to direct a pressurized fluid over the cutter of the first tubular catheter, and wherein the method further includes directing the pressurized fluid out of the distally-facing flush port over the cutter while reciprocating the first tubular catheter.

3. The method of claim 1 , wherein the cutter includes an electrode operably coupled to electrical circuitry that is configured to determine a state of the anatomical tissue.

4. The method of claim 1 , wherein the cutter includes an ultrasonically-driven cutter.

5. The method of claim 1 , wherein the cutter is operably coupled to electrical circuitry, wherein the electrical circuitry is configured to correlate a voltage drop or a current drop of the cutter with a state selected from the group consisting of (i) a state of tissue being cut by the electrode, (ii) a state of fouling of the electrode.

6. The method of claim 2 , wherein the pressurized fluid is a dielectric fluid.

7. The method of claim 6 , wherein the dielectric fluid includes a dextrose solution.

8. The method device of claim 1 , wherein the medical device further includes an actuator assembly coupled to a proximal region of the elongate tether, a proximal region of the first tubular catheter, and a proximal region of the second tubular catheter.

9. The method device of claim 8 , wherein the medical device further includes a third tubular catheter surrounding the second tubular catheter and being slidably displaceable along and with respect to the second tubular catheter, the third tubular catheter having a proximal end and a distal end, and further wherein a proximal end of the third tubular catheter is coupled to the actuator assembly.

10. The method of claim 9 , wherein the actuator assembly further includes a first actuator operably coupled to a proximal end of the first tubular catheter, and wherein the first actuator is configured to advance and retract the first tubular catheter proximally and distally over the elongate tether when the elongate tether is under tension.

11. The method of claim 10 , wherein the actuator assembly further includes a second actuator operably coupled to a proximal end of the second tubular catheter, wherein the second actuator is configured to advance and retract the second tubular catheter proximally and distally over the first tubular catheter, and further wherein the distal end of the second tubular catheter is capable of being retracted proximally past the distal end of the first tubular catheter.

12. The method of claim 11 , wherein the actuator assembly further includes a third actuator operably coupled to a proximal end of the third tubular catheter, wherein the third actuator is configured to advance and retract the third tubular catheter proximally and distally over the second tubular catheter, and further wherein the distal end of the third tubular catheter is capable of being retracted proximally past the distal end of the first tubular catheter and the distal end of the second tubular catheter.

13. The method of claim 1 , wherein each of the first tubular catheter and second tubular catheter to permit an operator to determine relative axial and rotational location of each of the first tubular catheter and second tubular catheter relative to each other and surrounding anatomy.

14. The method of claim 1 , further comprising conforming a shape of the first tubular catheter to match that of the native tissue obstruction such that the first tubular catheter is in at least substantially continuous contact with the native tissue obstruction along a length of the tissue obstruction.

15. The method of claim 1 , wherein the first tubular catheter is reciprocated along the elongate tether to cut an incision into the obstruction to enlarge an effective cross-sectional area of the left ventricular outflow tract of the patient.

16. The method of claim 1 , wherein the first tubular catheter is reciprocated along the elongate tether to cut an incision into the obstruction until the cutting element traverses a straight path between the distal end of the second tubular catheter and the tissue anchor.

17. The method of claim 1 , wherein the cutter is formed at least in part from radiopaque material.

18. The method of claim 1 , wherein the cutter includes a diamond coated wire.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2024
From: RAFIEE, NASSER, MR.; KOCATURK, OZGUR, DR.; MACDONALD, STUART, MR.; MACDONALD, BIWEI, MS.; HOUSE, MORGAN, MR.; RAFIEE, KOOSHA, MR.; DIEP, MAI LE, MS.
To: TRANSMURAL SYSTEMS LLC
Reel/Frame 066878/0631 →
Continuity (6)
Continuation PCTUS2023084621 · Dec 18, 2023
Provisional Application 63605856 · Dec 4, 2023
Provisional Application 63533271 · Aug 17, 2023
Provisional Application 63496566 · Apr 17, 2023
Provisional Application 63477317 · Dec 27, 2022
Related Publication 20240206815A1 · Jun 27, 2024
References Cited (117)
US 4493320A · Treat · 1985 [cited by applicant]
US 5341807A · Nardella · 1994 [cited by applicant]
US 5417697A · Wilk et al. · 1995 [cited by applicant]
US 5599300A · Weaver et al. · 1997 [cited by applicant]
US 5807279A · Viera · 1998 [cited by applicant]
US 6017340A · Cassidy et al. · 2000 [cited by applicant]
US 6050995A · Durgin · 2000 [cited by applicant]
US 6068637A · Popov et al. · 2000 [cited by applicant]
US 6071281A · Burnside · 2000 [cited by applicant]
US 6304776B1 · Muntermann · 2001 [cited by applicant]
US 6501992B1 · Belden et al. · 2002 [cited by applicant]
US 6517551B1 · Driskill · 2003 [cited by applicant]
US 6533782B2 · Howell et al. · 2003 [cited by applicant]
US 6582425B2 · Simpson · 2003 [cited by applicant]
US 6695836B1 · DeMello et al. · 2004 [cited by applicant]
US 7160295B1 · Garito et al. · 2007 [cited by applicant]
US 7303798B2 · Bavaro et al. · 2007 [cited by applicant]
US 7455646B2 · Richardson et al. · 2008 [cited by applicant]
US 8100903B2 · Kennedy, II · 2012 [cited by applicant]
US 8827948B2 · Romo et al. · 2014 [cited by applicant]
US 9282993B1 · Cohen et al. · 2016 [cited by applicant]
US 9572666B2 · Basude et al. · 2017 [cited by applicant]
US 9833272B2 · Sweeney · 2017 [cited by applicant]
US 9980716B2 · Harris et al. · 2018 [cited by applicant]
US 10792094B2 · Hrnicek · 2020 [cited by applicant]
US 10806509B2 · Gittard · 2020 [cited by applicant]
US 11337753B2 · Rafiee et al. · 2022 [cited by applicant]
US 20020042611A1 · Sliwa · 2002 [cited by applicant]
US 20030088195A1 · Vardi et al. · 2003 [cited by applicant]
US 20040267161A1 · Osborne et al. · 2004 [cited by applicant]
US 20050171532A1 · Ciarocca · 2005 [cited by applicant]
US 20050203500A1 · Saadat · 2005 [cited by applicant]
US 20070005084A1 · Clague et al. · 2007 [cited by applicant]
US 20070083168A1 · Whiting · 2007 [cited by examiner]
US 20070197939A1 · Wallace · 2007 [cited by examiner]
US 20070293857A1 · Blind et al. · 2007 [cited by applicant]
US 20080015409A1 · Barlow et al. · 2008 [cited by applicant]
US 20080228209A1 · DeMello et al. · 2008 [cited by applicant]
US 20090005637A1 · Chin · 2009 [cited by applicant]
US 20100057077A1 · Ducharme · 2010 [cited by applicant]
US 20100159396A1 · Specht et al. · 2010 [cited by applicant]
US 20100204560A1 · Salahieh · 2010 [cited by applicant]
US 20120083781A1 · Schall · 2012 [cited by examiner]
US 20120123328A1 · Williams · 2012 [cited by applicant]
US 20120259263A1 · Celermajer et al. · 2012 [cited by applicant]
US 20140276605A1 · Tejani et al. · 2014 [cited by applicant]
US 20140277333A1 · Lewis · 2014 [cited by examiner]
US 20160184557A1 · Call et al. · 2016 [cited by applicant]
US 20160317174A1 · Dake · 2016 [cited by applicant]
US 20170007277A1 · Drapeau et al. · 2017 [cited by applicant]
US 20180008268A1 · Khairkhakan · 2018 [cited by applicant]
US 20190175199A1 · Girdhar et al. · 2019 [cited by applicant]
US 20190269392A1 · Celermajer et al. · 2019 [cited by applicant]
US 20190298521A1 · Rafiee et al. · 2019 [cited by applicant]
US 20190343634A1 · Garvin · 2019 [cited by applicant]
US 20200146690A1 · Rothstein et al. · 2020 [cited by applicant]
US 20200383717A1 · Lederman et al. · 2020 [cited by applicant]
US 20210068892A1 · Urbanski et al. · 2021 [cited by applicant]
US 20210137579A1 · Rafiee et al. · 2021 [cited by applicant]
US 20210212756A1 · Rafiee et al. · 2021 [cited by applicant]
US 20210228227A1 · Vardi et al. · 2021 [cited by applicant]
US 20210307823A1 · Urbanski · 2021 [cited by examiner]
US 20220023046A1 · Basude · 2022 [cited by applicant]
US 20220096103A1 · Chou et al. · 2022 [cited by applicant]
US 20220110577A1 · Highsmith et al. · 2022 [cited by applicant]
US 20220117736A1 · Rafiee et al. · 2022 [cited by applicant]
US 20220296291A1 · Anderson et al. · 2022 [cited by applicant]
US 20220361908A1 · Karrowini et al. · 2022 [cited by applicant]
US 20230270424A1 · Sarabia · 2023 [cited by examiner]
US 20230301784A1 · Walters et al. · 2023 [cited by applicant]
US 20240099770A1 · Kim · 2024 [cited by examiner]
US 20250000575A1 · Lederman · 2025 [cited by examiner]
DE 10037660A1 · 2002 [cited by applicant]
DE 202010016945U1 · 2011 [cited by applicant]
EP 3175813B1 · 2020 [cited by applicant]
RU 2152757C1 · 2000 [cited by applicant]
WO 2018009718A1 · 2018 [cited by applicant]
WO 2019040943A1 · 2019 [cited by applicant]
WO 2019164806A1 · 2019 [cited by applicant]
WO 2021072331A1 · 2021 [cited by applicant]
WO 2022066621A1 · 2022 [cited by applicant]
WO 2023069983A1 · 2023 [cited by applicant]
WO 2023133499A1 · 2023 [cited by applicant]
Written Opinion mailed Jan. 27, 2022 for International Patent Application No. PCT/US2021/049952. [cited by applicant]
International Search Report mailed Jan. 27, 2022 for International Patent Application No. PCT/US2021/049952. [cited by applicant]
Unpublished International Patent Application No. PCT/US2021/049952 downloaded from ePCT on Jan. 28, 2022. [cited by applicant]
Written Opinion of the International Searching Authority for International Application No. PCT/US2018/048177 mailed Nov. 19, 2018. [cited by applicant]
International Search Report for International Application No. PCT/US2018/048177 mailed Dec. 20, 2018. [cited by applicant]
Khan et al., “Intentional Laceration of the Anterior Mitral Valve Leaflet to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Replacement”, JACC: Cardiovascular Interventions vol. 9 ,… [cited by applicant]
Babaliaros et al., “Intentional Percutaneous Laceration of the Anterior Mitral Leaflet to Prevent Outflow Obstruction During Transcatheter Mitral Valve Replacement First-in-Human Experience”, JACC: Cardiovascular Interv… [cited by applicant]
Lederman et al., “Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement From Computed Tomography to Basilica”, JACC: Cardiovascular Interventions vol. 12 , No. 13. 2019, pp. 1197-1216. [cited by applicant]
Khan et al., “Predicting Left Ventricular Outflow Tract Obstruction Despite Anterior Mitral Leaflet Resection the “Skirt NeoLVOT””, JACC: Cardiovascular Interventions Sep. 2019, vol. 11 , No. 9, pp. 1356-1359. [cited by applicant]
Case, “Tip to Base Lampoon to PRevent Left Ventricular Outflow Tract Obstruction in Valve in Valve Transcatheter Mitral Valve Replacement”, JACC: Cardiovascular Interventions, May 2020, vol. 13, No. 9, pp. 1126-1128. [cited by applicant]
Greenbaum et al., “First-in-human transcatheter pledglet-assisted suture tricuspid annuloplasty for severe tricuspid insufficiency,” Catheterization and Cardiovascular Interventions, May 2020, 5 pages. [cited by applicant]
Kamioka et al., “Bi-Silica During Transcatheter Aortic Valve Replacement for Noncalcific Aortic Insufficiency: Initial Human Experience”, JACC: Cardiovascular Interventions, Nov., 2018, vol. 11, No. 21, pp. 2237-2239. [cited by applicant]
Kasel et al, “International Lampoon: First European experience with laceration of the anterior mitral valve leaflet prior to transseptal transcatheter mitral valve implantation”, Eurointervention, Sep. 2018, col. 14, No… [cited by applicant]
Khan et al, “The Basilica Trial: Prospective Multicenter Investigation of Intentional Leaflet Laceration to Prevent TAVR Coronary Obstruction”, JACC: Cardiovascular Interventions, 2019, vol. 12, No. 13, pp. 1240-1252. [cited by applicant]
Khan et al, “Transcatheter Mitral Valve Replacement after Transcatheter Electrosurgical Laceration of Alfieri stitch (Elastic): First in human report,” JACC: Cardiovascular Interventions, Apr. 2018, vol. 11, No. 8, pp. … [cited by applicant]
Khan et al, “Transcatheter Electrosurgery: JACC State of the art review,” Journal of the American College of Cardiology, Mar. 2020, vol. 75, No. 12, pp. 1455-1470. [cited by applicant]
Khan et al., “Antetrior Leaflet Laceration to Prevent Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Replacement,” Journal of the American College of Cardiology, May 2019, vol. 73, No. 20, pp. 2… [cited by applicant]
Khan et al, “Rescue Lampoon to Treat Transcatheter Mitral Valve Replacement—Associated Left Ventricular Outflow Tract Obstruction”, JACC: Cardiovascular Interventions, Jul. 2019, vol. 12, No. 13, pp. 1283-1284. [cited by applicant]
Lisko et al., “Pachyderm Shape guiding catheters to simplify Basilica leaflet traversal,” Cardiovsacular Revascularization Medicine, Sep. 2019, vol. 20, No. 9, pp. 782-785. [cited by applicant]
Lisko et al., “Electrosurgical detachment of Mitraclips from the anterior mitral leaflet prior to transcatheter mitral valve implantation,” JACC: Cardiovascular Interventions, Oct. 2020, vol. 13, No. 20, pp. 2361-2370. [cited by applicant]
Khan et al., “Lampoon to facilitate tendyn Antetrior Leaflet Laceration to Prevent Ventricular Outflow Tract Obstruction During Transcatehter Mitral Valve Replacement,” Journal of the American College of Cardiology, May… [cited by applicant]
International Search Report mailed Jun. 22, 2023 for International Application No. PCT/US23/60223. [cited by applicant]
Written Opinion and International Search Report mailed Mar. 1, 2021 for International Patent Application No. PCT/US2020/055160. [cited by applicant]
Written Opinion and International Search Report mailed Oct. 22, 2021 for International Patent Application No. PCT/US2021/040511. [cited by applicant]
Extended European Search Report for Application No. 18848165.9 dated Apr. 30, 2021. [cited by applicant]
Supplementary European Search Report and European Search Opinion for Application No. 19756527.8 dated Oct. 18, 2021. [cited by applicant]
International Search Report for co-pending international application No. PCT./US2023/084619, mailed Apr. 17, 2024. [cited by applicant]
International Search Report for co-pending international application No. PCT/US2023/084620, mailed Apr. 18, 2024. [cited by applicant]
International Search Report for co-pending international application No. PCT/US2023/084621, mailed May 30, 2024. [cited by applicant]
Written Opinion of the International Searching Authority for co-pending international application No. PCT/US2023/084619, mailed Apr. 17, 2024. [cited by applicant]
Written Opinion of the International Searching Authority for co-pending international application No. PCT/US2023/084620, mailed Apr. 18, 2024. [cited by applicant]
Written Opinion of the International Searching Authority for co-pending international application No. PCT/US2023/084621, mailed May 30, 2024. [cited by applicant]
Non-final office action mailed Mar. 14, 2024 in co-pending U.S. Appl. No. 18/390,687. [cited by applicant]
Non-final office action mailed Apr. 8, 2024 in co-pending U.S. Appl. No. 18/390,711. [cited by applicant]